Corne P. De Vogel

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

In vitro activity of antibiotic monotherapy and combination therapy with bacteriophages against Staphylococcus aureus LVAD-driveline infections.

In vitro activity of antibiotic monotherapy and combination therapy with bacteriophages against Staphylococcus aureus LVAD-driveline infections.

Journal: Journal of clinical microbiology

Published: October 09, 2025

Proteomic identification of PA2146 as a biofilm marker of Pseudomonas aeruginosa on endoscope channel material.

Proteomic identification of PA2146 as a biofilm marker of Pseudomonas aeruginosa on endoscope channel material.

Journal: Biofilm

Published: June 09, 2025

Towards enhanced translational value: preclinical drug activity testing against actively multiplying, nutrient-starved and pellicle biofilm-embedded Mycobacterium abscessus.

Towards enhanced translational value: preclinical drug activity testing against actively multiplying, nutrient-starved and pellicle biofilm-embedded Mycobacterium abscessus.

Journal: The Journal of antimicrobial chemotherapy

Published: April 16, 2025

Unraveling antibiotic resistance mechanisms in Mycobacterium abscessus: the potential role of efflux pumps.

Unraveling antibiotic resistance mechanisms in Mycobacterium abscessus: the potential role of efflux pumps.

Journal: Journal of global antimicrobial resistance

Published: August 08, 2022

Isothermal microcalorimetry vs checkerboard assay to evaluate in-vitro synergism of meropenem-amikacin and meropenem-colistin combinations against multi-drug-resistant Gram-negative pathogens.

Isothermal microcalorimetry vs checkerboard assay to evaluate in-vitro synergism of meropenem-amikacin and meropenem-colistin combinations against multi-drug-resistant Gram-negative pathogens.

Journal: International journal of antimicrobial agents

Published: January 17, 2022

Effective antimicrobial combination in vivo treatment predicted with microcalorimetry screening.

Effective antimicrobial combination in vivo treatment predicted with microcalorimetry screening.

Journal: The Journal of antimicrobial chemotherapy

Published: June 18, 2020

Isothermal microcalorimetry minimal inhibitory concentration testing in extensively drug resistant Gram-negative bacilli: a multicentre study.

Isothermal microcalorimetry minimal inhibitory concentration testing in extensively drug resistant Gram-negative bacilli: a multicentre study.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: September 30, 2019

Omadacycline as a promising new agent for the treatment of infections with Mycobacterium abscessus.

Omadacycline as a promising new agent for the treatment of infections with Mycobacterium abscessus.

Journal: The Journal of antimicrobial chemotherapy

Published: February 15, 2019

A model-informed preclinical approach for prediction of clinical pharmacodynamic interactions of anti-TB drug combinations.

A model-informed preclinical approach for prediction of clinical pharmacodynamic interactions of anti-TB drug combinations.

Journal: The Journal of antimicrobial chemotherapy

Published: March 31, 2017

Correction: Naturally Acquired Human Immunity to Pneumococcus Is Dependent on Antibody to Protein Antigens.

Correction: Naturally Acquired Human Immunity to Pneumococcus Is Dependent on Antibody to Protein Antigens.

Journal: PLoS pathogens

Published: March 09, 2017

The role of the time-kill kinetics assay as part of a preclinical modeling framework for assessing the activity of anti-tuberculosis drugs.

The role of the time-kill kinetics assay as part of a preclinical modeling framework for assessing the activity of anti-tuberculosis drugs.

Journal: Tuberculosis (Edinburgh, Scotland)

Published: August 28, 2016

Activity of moxifloxacin and linezolid against Mycobacterium tuberculosis in combination with potentiator drugs verapamil, timcodar, colistin and SQ109.

Activity of moxifloxacin and linezolid against Mycobacterium tuberculosis in combination with potentiator drugs verapamil, timcodar, colistin and SQ109.

Journal: International journal of antimicrobial agents

Published: July 04, 2016

Showing 1-12 of 23

Last Updated: 09/26/2026